Intracellular Antibiotic Activity in Human Neutrophils

Human neutrophils are frontline defenders against bacterial infection, engulfing pathogens into specialised compartments known as phagosomes. While many antibiotics exhibit potent activity in extracellular environments, their capacity to penetrate neutrophils and eliminate intracellular pathogens varies widely. Intracellular antibiotic activity depends on physicochemical properties such as lipophilicity, ionisation and molecular size, which govern diffusion through neutrophil membranes and accumulation in acidic phagosomes. Once inside, antibiotics must retain bactericidal or bacteriostatic function in the complex milieu of reactive oxygen species, proteolytic enzymes and fluctuating pH. Effective intracellular therapies can prevent bacterial evasion strategies, such as sequestration within neutrophils acting as “Trojan horses”, and may reduce systemic dissemination. Understanding these dynamics is essential for optimising treatment of invasive infections, particularly in immune-compromised or critically ill patients where dysfunctional neutrophils can harbour persistent pathogens. Recent advances in live-cell imaging, single-cell analysis and transcriptomics have begun to unravel the molecular determinants of antibiotic uptake and efficacy within these phagocytes, pointing towards more targeted therapeutic strategies.

Research from Nature Portfolio

Recent studies have shown that lipophilic fluoroquinolones accumulate rapidly within neutrophil phagosomes, achieving concentrations up to tenfold higher than in plasma and correlating with enhanced clearance of intracellular Staphylococcus aureus. High-resolution live-cell microscopy revealed real-time co-localisation of antibiotic molecules and bacterial targets, allowing quantification of killing kinetics at single-cell level. In parallel, transcriptomic profiling of neutrophils exposed to different antibiotic classes identified key solute carriers and proton pumps that facilitate drug uptake and retention under acidic conditions. A complementary investigation used microfluidic chambers to model tissue-like environments and demonstrated that co-administration of rifamycins with agents that modulate phagosomal pH can significantly boost intracellular bactericidal rates without compromising neutrophil viability. Together, these findings elucidate the interplay between antibiotic chemistry, neutrophil physiology and pathogen survival strategies, offering new avenues to optimise intracellular therapy.

Intracellular Antibiotic Activity in Human Neutrophils publication trend

The graph below shows the total number of articles in intracellular antibiotic activity in human neutrophils across all publications each year (not limited to Nature Index journals).

Technical terms

Neutrophil: A type of white blood cell that engulfs and destroys invading microorganisms.

Phagosome: An intracellular vesicle within phagocytes where ingested pathogens are degraded.

Intracellular antibiotic activity: The ability of an antibiotic to enter host cells and inhibit or kill pathogens residing within.

Lipophilicity: The tendency of a molecule to dissolve in lipids, influencing membrane permeability.

Trojan horse mechanism: A process by which pathogens survive inside immune cells and spread through the host when cells die.

References

1. Intracellular Penetration and Effects of Antibiotics on Staphylococcus aureus Inside Human Neutrophils: A Comprehensive Review. Antibiotics (2019).
2. Subinhibitory Antimicrobial Concentrations: A Review of In Vitro and In Vivo Data. Canadian Journal of Infectious Diseases and Medical Microbiology (1991).
3. Assessment of phagocytic activity when using antibiotics and bacteriophages for the therapy of experimental peritonitis induced by Escherichia coli. Frontiers in Immunology (2013).